Content about Pharmacology

September 18, 2012

Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.


NEW YORK — Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.


September 18, 2012

2012 is turning out to be a pretty important year for generic drugs, important enough that some of the things happening over the past several months have begged comparison to 1984, probably the biggest milestone year for the industry.


2012 is turning out to be a pretty important year for generic drugs, important enough that some of the things happening over the past several months have begged comparison to 1984, probably the biggest milestone year for the industry.


September 18, 2012

For branded drug makers, the pharmaceutical patent cliff has never loomed higher or steeper. The exposure of so many of the world’s biggest-selling medicines to generic competition for the first time is redefining the pricing model for many of the most widely prescribed classes of pharmaceuticals.

For branded drug makers, the pharmaceutical patent cliff has never loomed higher or steeper. The exposure of so many of the world’s biggest-selling medicines to generic competition for the first time is redefining the pricing model for many of the most widely prescribed classes of pharmaceuticals — reducing costs for health plans, payers and patients; scrambling drug makers’ balance sheets; and potentially boosting both drug utilization and adherence rates as reduced out-of-pocket costs induce more patients to fill their prescriptions.


September 17, 2012

The Food and Drug Administration has approved a generic ulcer treatment made by Wockhardt, the Indian drug maker said Monday.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic ulcer treatment made by Wockhardt, the Indian drug maker said Monday.

Wockhardt announced the approval and launch of lansoprazole delayed-release capsules in the 15-mg and 30-mg strengths. The drug is a generic version of Prevacid, which Takeda markets in the United States.

The drug has a market of about $700 million in the United States, according to IMS Health.

September 17, 2012

A lot of people have quite a few things to say about healthcare reform, whether they favor or oppose it. But supporters of the law show an altruistic sensibility and an understanding of how the law would benefit other Americans, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

A lot of people have quite a few things to say about healthcare reform, whether they favor or oppose it. But supporters of the law show an altruistic sensibility and an understanding of how the law would benefit other Americans, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

September 17, 2012

VoicePort has launched its new appointment scheduler services application.

ROCHESTER, N.Y. — VoicePort has launched its new appointment scheduler services application.

Part of the company's platform of unified patient communications, the app is a self-serve interface for patients to schedule a host of health-and-wellness appointments through a pharmacy's website.

September 17, 2012

Walgreens and Rx Response on Monday announced a new healthcare collaboration developed to help ensure patient access to medications following a natural disaster.

WASHINGTON — Walgreens and Rx Response on Monday announced a new healthcare collaboration developed to help ensure patient access to medications following a natural disaster. 

September 14, 2012

The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.

PHILADELPHIA — The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.

Lannett announced the approval of butalbital, acetaminophen and caffeine tablets in the 50-mg/325-mg/40-mg strength. the drug is a generic version of Watson Pharmaceuticals' Fioricet.

Branded and generic versions of the drug had sales of $30 million during the 12-month period ended in July, including $15 million for branded Fioricet. Lannett plans to start shipping its version next month, the company said.

September 14, 2012

The Food and Drug Administration on Thursday alerted the public that certain external analgesics have been associated with burns.

 SILVER SPRING, Md. — The Food and Drug Administration on Thursday alerted the public that certain external analgesics have been associated with burns. Most of the reported cases involved products containing higher concentrations of menthol and methyl salicylate (greater than 3% menthol or 10% methyl salicylate). Few of the cases involved capsaicin, the FDA reported. 

September 14, 2012

Two generic drug makers have settled with a subsidiary of Johnson & Johnson and another company concerning a drug used to treat attention deficit hyperactivity disorder.

HAYWARD, Calif. — Two generic drug makers have settled with a subsidiary of Johnson & Johnson and another company concerning a drug used to treat attention deficit hyperactivity disorder.

Impax Labs and Teva Pharmaceuticals USA had settled a patent infringement suit with Janssen Pharmaceuticals and Alza over Concerta (methylphenidate hydrochloride) extended-release tablets in the 18-mg, 27-mg, 36-mg and 54-mg strengths.

September 14, 2012

The specialty pharmacy operated by Omnicare Specialty Care Group has been added to the limited distribution network for a drug used to treat a hereditary degenerative disorder.

ORLANDO, Fla. — The specialty pharmacy operated by Omnicare Specialty Care Group has been added to the limited distribution network for a drug used to treat a hereditary degenerative disorder.

Omnicare said Friday that Lundbeck had added Advanced Care Scripts to its network for Xenaziner (tetrabenazine). The drug is used to treat involuntary movements known as chorea associated with Huntington's disease. Chroea affects about 90% of people with Huntington's and is considered a hallmark of the disease, according to studies.

September 14, 2012

Costs are the biggest concern for opponents of healthcare reform. They’ve done the math — additional healthcare consumers means care that’s both more expensive and harder to come by. As many as 3-in-4 consumers who are not big fans of healthcare reform share that concern — 30% of those consumers suggested it’s their greatest concern, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August. A reduction in care quality was concern No. 2 (62%), and a lack of choice over which practitioner to see was concern No. 3 (58%). But at least they’ll still be covered — only 22% said they were concerned their employers would stop the coverage.

Costs are the biggest concern for opponents of healthcare reform. They’ve done the math — additional healthcare consumers means care that’s both more expensive and harder to come by. As many as 3-in-4 consumers who are not big fans of healthcare reform share that concern — 30% of those consumers suggested it’s their greatest concern, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August. A reduction in care quality was concern No.

September 14, 2012

Walgreens announced plans to close more than half of the stores it is acquiring in its deal with USA Drug.

DEERFIELD, Ill. — Walgreens announced plans to close more than half of the stores it is acquiring in its deal with USA Drug.

The company — which said in July it would purchase the mid-South drug store chain for approximately $438 million — confirmed it would close approximately 76 stores across the region. USA Drug operates 144 stores under the USA Drug, Super D Drug, May's Drug, Med-X and Drug Warehouse banners.

September 13, 2012

The Food and Drug Administration has approved a generic psychiatric drug made by Lupin Pharmaceuticals, Lupin said Thursday.

BALTIMORE — The Food and Drug Administration has approved a generic psychiatric drug made by Lupin Pharmaceuticals, Lupin said Thursday.

The Indian drug maker announced the approval of escitalopram tablets in the 5-mg, 10-mg and 20-mg strengths, used for acute and maintenance treatment of major depressive disorder in adults and adolescents and for acute treatment of general anxiety disorder in adults.

September 13, 2012

The Food and Drug Administration has approved a new drug for multiple sclerosis.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved a new drug for multiple sclerosis.

Sanofi subsidiary Genzyme announced that the FDA had approved Aubagio (teriflunomide) as a once-daily, oral treatment for patients with relapsing MS.

September 13, 2012

Pfizer has inked a deal with a Chinese drug maker to make branded-generic drugs for China and global markets, the companies said.

HANGZHOU, China — Pfizer has inked a deal with a Chinese drug maker to make branded-generic drugs for China and global markets, the companies said.

September 12, 2012

GlaxoSmithKline is offering a recycling program for empty inhalers at retail pharmacies in 31 cities, the drug maker said Wednesday.

NEW YORK — GlaxoSmithKline is offering a recycling program for empty inhalers at retail pharmacies in 31 cities, the drug maker said Wednesday.

The company announced its "Complete the Cycle" program for GSK respiratory inhalers, starting in October.

September 12, 2012

When all things are equal — particularly, cost! — there is no doubt that satisfied pharmacy customers are fiercely loyal to their preferred stores. But like Cyndi Lauper once sang, "Money changes everything," particularly for the 32% of Patient Views respondents who said they would be willing to change pharmacies for a savings of $5 or less, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

When all things are equal — particularly, cost! — there is no doubt that satisfied pharmacy customers are fiercely loyal to their preferred stores. But like Cyndi Lauper once sang, "Money changes everything," particularly for the 32% of Patient Views respondents who said they would be willing to change pharmacies for a savings of $5 or less, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August. How low will they go? Eight percent would switch for less than a buck.

September 12, 2012

Some common patient complaints regarding mail-order pharmacies and their captive consumers’ lack of choice to switch to another pharmacy if they encounter poor service are highlighted in a new video released Wednesday by the National Community Pharmacists Association.

ALEXANDRIA, Va. — Some common patient complaints regarding mail-order pharmacies and their captive consumers’ lack of choice to switch to another pharmacy if they encounter poor service are highlighted in a new video released Wednesday by the National Community Pharmacists Association.

September 12, 2012

The Mentholatum Co.’s Softlips brand has announced the launch of a new Halloween-themed lip balm that is hitting retail stores in early September.

ORCHARD PARK, N.Y. — The Mentholatum Co.’s Softlips brand has announced the launch of a new Halloween-themed lip balm that is hitting retail stores in early September.

The new Softlips Marshmallow Ghost will be featured as part of a Halloween-themed two-pack that includes the Softlips Vanilla lip balm.

September 12, 2012

Drug maker Johnson & Johnson said Wednesday that patients applying for its HIV drug assistance program would have a more streamlined application process.

NEW BRUNSWICK, N.J. — Drug maker Johnson & Johnson said Wednesday that patients applying for its HIV drug assistance program would have a more streamlined application process.

September 12, 2012

Drug maker Shire is seeking Food and Drug Administration approval for a new usage for a drug used to treat attention deficit hyperactivity disorder, the company said Wednesday.

PHILADELPHIA — Drug maker Shire is seeking Food and Drug Administration approval for a new usage for a drug used to treat attention deficit hyperactivity disorder, the company said Wednesday.

Shire announced that the FDA had accepted its regulatory approval application for Vyvanse (lisdexamfetamine dimesylate) capsules for maintenance treatment of ADHD in patients ages 6 to 17 years. There currently are no stimulants approved for maintenance treatment of the condition in that age group, Shire said, and the FDA said it would complete its review by April 2013.

September 12, 2012

Most advertisements for over-the-counter versions of drugs did contain significantly less information about the risks of the medication, compared with the ads for the drug prior to its transition to OTC status, according to new research sponsored by CVS Caremark.

WOONSOCKET, R.I. — Most advertisements for over-the-counter versions of drugs did contain significantly less information about the risks of the medication, compared with the ads for the drug prior to its transition to OTC status, according to new research sponsored by CVS Caremark.

The research, published in this week's issue of the Journal of the American Medical Association, identified differences between consumer-directed advertisements for drugs when they are available by prescription only, compared with when they transition to OTC.

September 11, 2012

Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

HYDERABAD, India — Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

Dr. Reddy's announced the launch of metoprolol succinate extended-release tablets in the 25-mg, 50-mg, 100-mg and 200-mg strengths. The drug will be available in bottle counts of 100 and 500.

The drug is a generic version of AstraZeneca's Toprol-XL, branded and generic versions of which had sales of about $1.13 billion during the 12-month period that ended in June, according to IMS Health.

September 11, 2012

The Food and Drug Administration on Thursday issued warning letters to PruTect Rx, of Highlands Ranch, Colo., and Trinity Sports Group, of Plano, Texas, for promoting products labeled as dietary supplements with claims to treat concussions and prevent or treat post-concussion syndrome and other neurological disorders.

SILVER SPRING, Md. — The Food and Drug Administration on Thursday issued warning letters to PruTect Rx, of Highlands Ranch, Colo., and Trinity Sports Group, of Plano, Texas, for promoting products labeled as dietary supplements with claims to treat concussions and prevent or treat post-concussion syndrome and other neurological disorders.